iScience (Jun 2021)

Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles

  • Shahan Syed,
  • Eija Nissilä,
  • Hanna Ruhanen,
  • Satoshi Fudo,
  • Meztlli O. Gaytán,
  • Sanna P. Sihvo,
  • Martina B. Lorey,
  • Jari Metso,
  • Katariina Öörni,
  • Samantha J. King,
  • Oommen P. Oommen,
  • Matti Jauhiainen,
  • Seppo Meri,
  • Reijo Käkelä,
  • Karita Haapasalo

Journal volume & issue
Vol. 24, no. 6
p. 102535

Abstract

Read online

Summary: High-density lipoproteins (HDLs) are a group of different subpopulations of sialylated particles that have an essential role in the reverse cholesterol transport (RCT) pathway. Importantly, changes in the protein and lipid composition of HDLs may lead to the formation of particles with reduced atheroprotective properties. Here, we show that Streptococcus pneumoniae pneumolysin (PLY) and neuraminidase A (NanA) impair HDL function by causing chemical and structural modifications of HDLs. The proteomic, lipidomic, cellular, and biochemical analysis revealed that PLY and NanA induce significant changes in sialic acid, protein, and lipid compositions of HDL. The modified HDL particles have reduced cholesterol acceptor potential from activated macrophages, elevated levels of malondialdehyde adducts, and show significantly increased complement activating capacity. These results suggest that accumulation of these modified HDL particles in the arterial intima may present a trigger for complement activation, inflammatory response, and thereby promote atherogenic disease progression.

Keywords